cdmo.directory
← Compare landing

BSP Pharmaceuticals vs Wheeler Bio

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryBSP PharmaceuticalsWheeler Bio
SummaryBSP Pharmaceuticals is a CDMO specializing in development and manufacturing of cytotoxic oncology drugs, ADCs, peptides, proteins, and lipid-based formulations from preclinical GLP through commercial supply.Oklahoma-based CDMO specializing in antibody-based therapeutics from cell line development through cGMP manufacturing. Offers ModularCMC platform with phase-appropriate work packages and high-touch project management.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Lipid Nanoparticle (LNP) Formulation
  • Oligonucleotide Manufacturing
  • Peptide Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • Oral Solid Dosage Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Peptide
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
Development capabilities
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Oral Solid Dose (OSD)
  • Expression: Mammalian
  • Max chemical: Commercial (>100 kg / tonne)
  • HPAPI
  • Cryogenic (−80 °C)
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Single-Use / Disposable
Locations
  • Headquarters and Manufacturing Plant, Latina Scalo, Lazio, Italy
  • Commercial Branch, Princeton, New Jersey, United States
  • Headquarters, Oklahoma City, Oklahoma, USA
Certifications
  • Italian Tax Authority · Identifier: P.IVA/C.F.02314650595
Data not yet provided.

Find similar companies

BSP Pharmaceuticals alternatives · Wheeler Bio alternatives

Markdown mirror: /compare/bsppharmaceuticals/wheeler-bio.md